Human brain organoids maintained in a laboratory for about seven years continued to mature in ways resembling cells in normal brain development, according to a US-led study published in Nature. The experiment extended the reported lifespan of such models far beyond the previous record of just under two years.
The organoids were peppercorn-sized clusters grown from stem cells. Researchers use these simplified biological models to study human brain cells and investigate potential medicines without relying only on animals. Most survive for months, restricting experiments largely to early developmental stages. Human brains, by comparison, take nearly two decades to develop fully.
Paola Arlotta, the study’s senior author and a Harvard University professor, said the seven-year cultures were the oldest brain organoids reported. The team found that development continued even though the cells had never formed within an embryo or body.
Researchers assessed the cells with three recently developed genetic clocks, tools that estimate biological age from cellular characteristics. All three indicated changes over time that paralleled ageing in ordinary brain cells. The study described the organoids as recording elapsed time and retaining the effects of developmental stages they had already passed through.
That language does not mean the clusters formed personal memories. Arlotta explained that prior development was preserved at the cellular level. She characterised organoids as models, or avatars, that are much less complex than a brain and receive no sensory information. Scientists broadly agree that these systems cannot support consciousness or other higher-order brain functions.
The team also tested whether cells of different ages maintained distinct developmental schedules. Researchers combined cells grown for one year with cells only two weeks old, creating what they called a chimera. The older population then advanced rapidly and began producing neurons that would ordinarily appear after about four months. The result suggests the cellular state accumulated during earlier growth can influence later development even after cells enter a mixed-age environment.
Arlotta said such an approach might eventually allow researchers to accelerate the production of particular kinds of brain cells. That remains a future possibility rather than a demonstrated medical application.
Long-lived organoids could give scientists a wider experimental window for examining how conditions including autism and schizophrenia emerge and change during later stages of development. They also raise basic questions about how long neural tissue can persist without the illnesses and bodily decline that limit an organism’s life. Arlotta said nobody knows whether organoids could outlive people, though she suspected they might survive somewhat longer.
The particular cultures used in the study will not test that limit: they were destroyed after the research. Their seven-year run nevertheless establishes that isolated human neural cells can follow an extended developmental timetable in laboratory conditions.
